Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Oxybutynin Cl
DRUG
2 trials
Sponsors
Toronto Rehabilitation Institute
, Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Conditions
Neurogenic Detrusor Overactivity
Overactive Bladder
Spinal Cord Injury
Phase 4
Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity
Completed
NCT00800462
Toronto Rehabilitation Institute
Neurogenic Detrusor Overactivity, Spinal Cord Injury
Start: 2008-03-31
End: 2012-12-31
Updated: 2013-04-08
Unknown Phase
Treatment of Overactive Bladder With Anticholinergic Agents
Active, not recruiting
NCT07046156
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Overactive Bladder
Start: 2022-09-01
End: 2026-06-01
Target: 120
Updated: 2025-07-01
Related Papers
Response to anticholinergic therapy and its predictors in pediatric overactive bladder.
2025-11-03